VAP-B Antibody (699811) [Alexa Fluor® 700]

• Reactivity: Rt
• Applications: WB, IHC
• Clone: 699811
• Clonality: Monoclonal
• Host: Mouse
• Conjugate: Alexa Fluor 700

VAP-B Antibody (699811) [Alexa Fluor® 700] Summary

• Immunogen: E. coli-derived recombinant rat VAP-B
  Ala2-Pro132
  Accession # Q9Z269
• Specificity: Detects rat VAP-B in direct ELISAs and Western blots. In direct ELISAs, 100% cross-reactivity with recombinant human (rh) VAP-B and approximately 50% cross-reactivity with rhVAP-A is observed.
• Isotype: IgG1
• Clonality: Monoclonal
• Host: Mouse
• Purity Statement: Protein A or G purified

Applications/Dilutions

• Dilutions:
  • Immunohistochemistry
  • Western Blot

Packaging, Storage & Formulations

• Storage: Protect from light. Do not freeze. 12 months from date of receipt, 2 to 8 °C as supplied
• Buffer: Supplied 0.2mg/ml in 1X PBS with RDF1 and 0.09% Sodium Azide

Notes

This product is produced by and ships from R&D Systems, Inc., a Bio-Techne brand.

Alternate Names for VAP-B Antibody (699811) [Alexa Fluor® 700]

• ALS8
• ALS8VAMP-B/VAMP-C
• VAMP (vesicle-associated membrane protein)-associated protein B and C
• VAMP-associated 33 kDa protein
• VAMP-associated protein B/C
• VAMP-B
• VAMP-C
• VAPB
• VAP-B
• VAP-B/VAP-C
• VAPC
• VAP-C
• vesicle-associated membrane protein-associated protein B/C

Background

Vesicle-associated membrane protein (VAMP)-associated protein B (VAP-B; also VAMP-B) is an ~30 kDa ubiquitously expressed type IV transmembrane protein belonging to the VAP family. It is found in endoplasmic reticulum (ER), Golgi and other membranes as a homodimer or a heterodimer with VAP-A, probably associating through the transmembrane regions. Human VAP-B cDNA encodes a 222 amino acids (aa) cytoplasmic domain and a 21 aa C-terminal membrane anchor. Rat VAP-B shares 89% and 96% aa identity with mouse and human VAP-B, respectively. A soluble form can function as a ligand for EPH receptors. A human polymorphism of VAP-B, P56S, is found in three familial motor neuron diseases, notably the amylotrophic lateral sclerosis variant ALS8.

Limitations

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.